Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Nitrosatable drug exposure during early pregnancy and neural tube defects in offspring: National Birth Defects Prevention Study.

Brender JD, Werler MM, Kelley KE, Vuong AM, Shinde MU, Zheng Q, Huber JC Jr, Sharkey JR, Griesenbeck JS, Romitti PA, Langlois PH, Suarez L, Canfield MA, The National Birth Defects Prevention Study.

Am J Epidemiol. 2011 Dec 1;174(11):1286-95. doi: 10.1093/aje/kwr254.

2.

Impact of Periconceptional Use of Nitrosatable Drugs on the Risk of Neural Tube Defects.

Benedum CM, Yazdy MM, Mitchell AA, Werler MM.

Am J Epidemiol. 2015 Oct 15;182(8):675-84. doi: 10.1093/aje/kwv126.

3.

Dietary nitrites and nitrates, nitrosatable drugs, and neural tube defects.

Brender JD, Olive JM, Felkner M, Suarez L, Marckwardt W, Hendricks KA.

Epidemiology. 2004 May;15(3):330-6.

PMID:
15097014
4.

Nitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformations.

Brender JD, Werler MM, Shinde MU, Vuong AM, Kelley KE, Huber JC Jr, Sharkey JR, Griesenbeck JS, Romitti PA, Malik S, Suarez L, Langlois PH, Canfield MA; National Birth Defects Prevention Study..

Birth Defects Res A Clin Mol Teratol. 2012 Sep;94(9):701-13. doi: 10.1002/bdra.23060.

5.

Prenatal exposure to nitrosatable drugs, vitamin C, and risk of selected birth defects.

Shinde MU, Vuong AM, Brender JD, Werler MM, Kelley KE, Huber JC Jr, Sharkey JR, Zheng Q, Suarez L, Langlois PH, Canfield MA, Romitti PA, Malik S; National Birth Defects Prevention Study..

Birth Defects Res A Clin Mol Teratol. 2013 Aug;97(8):515-31. doi: 10.1002/bdra.23137.

PMID:
23716465
6.

Nitrosatable Drug Exposure during Pregnancy and Preterm and Small-for-Gestational-Age Births.

Vuong AM, Shinde MU, Brender JD, Shipp EM, Huber JC Jr, Zheng Q, McDonald TJ, Sharkey JR, Hoyt AT, Werler MM, Kelley KE, Langlois PH, Canfield MA; National Birth Defects Prevention Study..

Paediatr Perinat Epidemiol. 2015 Jan;29(1):60-71. doi: 10.1111/ppe.12169.

PMID:
25492517
7.

Prenatal Exposure to Nitrosatable Drugs, Dietary Intake of Nitrites, and Preterm Birth.

Vuong AM, Shinde MU, Brender JD, Shipp EM, Huber JC Jr, Sharkey JR, McDonald TJ, Werler MM, Kelley KE, Griesenbeck JS, Langlois PH, Canfield MA; National Birth Defects Prevention Study Investigators..

Am J Epidemiol. 2016 Apr 1;183(7):634-42. doi: 10.1093/aje/kwv250.

PMID:
26953287
8.

Prevalence and patterns of nitrosatable drug use among U.S. women during early pregnancy.

Brender JD, Kelley KE, Werler MM, Langlois PH, Suarez L, Canfield MA; National Birth Defects Prevention Study..

Birth Defects Res A Clin Mol Teratol. 2011 Apr;91(4):258-64. doi: 10.1002/bdra.20808.

9.

Maternal prenatal exposure to nitrosatable drugs and childhood brain tumours.

McKean-Cowdin R, Pogoda JM, Lijinsky W, Holly EA, Mueller BA, Preston-Martin S.

Int J Epidemiol. 2003 Apr;32(2):211-7.

10.

Maternal dietary intake of nitrates, nitrites and nitrosamines and selected birth defects in offspring: a case-control study.

Huber JC Jr, Brender JD, Zheng Q, Sharkey JR, Vuong AM, Shinde MU, Griesenbeck JS, Suarez L, Langlois PH, Canfield MA, Romitti PA, Weyer PJ; National Birth Defects Prevention Study..

Nutr J. 2013 Mar 21;12:34. doi: 10.1186/1475-2891-12-34.

11.

Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies.

Wilson RD; Genetics Committee., Wilson RD, Audibert F, Brock JA, Carroll J, Cartier L, Gagnon A, Johnson JA, Langlois S, Murphy-Kaulbeck L, Okun N, Pastuck M; Special Contributors., Deb-Rinker P, Dodds L, Leon JA, Lowel HL, Luo W, MacFarlane A, McMillan R, Moore A, Mundle W, O'Connor D, Ray J, Van den Hof M.

J Obstet Gynaecol Can. 2015 Jun;37(6):534-52. English, French.

PMID:
26334606
12.

Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies.

Wilson RD, Johnson JA, Wyatt P, Allen V, Gagnon A, Langlois S, Blight C, Audibert F, Désilets V, Brock JA, Koren G, Goh YI, Nguyen P, Kapur B; Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada and The Motherrisk Program..

J Obstet Gynaecol Can. 2007 Dec;29(12):1003-26. English, French. Erratum in: J Obstet Gynaecol Can. 2008 Mar;30(3):193. Goh, Ingrid [corrected to Goh, Y Ingrid].

PMID:
18053387
13.

Prenatal nitrate intake from drinking water and selected birth defects in offspring of participants in the national birth defects prevention study.

Brender JD, Weyer PJ, Romitti PA, Mohanty BP, Shinde MU, Vuong AM, Sharkey JR, Dwivedi D, Horel SA, Kantamneni J, Huber JC Jr, Zheng Q, Werler MM, Kelley KE, Griesenbeck JS, Zhan FB, Langlois PH, Suarez L, Canfield MA; National Birth Defects Prevention Study..

Environ Health Perspect. 2013 Sep;121(9):1083-9. doi: 10.1289/ehp.1206249.

14.

Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States.

Mosley BS, Cleves MA, Siega-Riz AM, Shaw GM, Canfield MA, Waller DK, Werler MM, Hobbs CA; National Birth Defects Prevention Study..

Am J Epidemiol. 2009 Jan 1;169(1):9-17. doi: 10.1093/aje/kwn331.

15.
16.

Effects and safety of periconceptional oral folate supplementation for preventing birth defects.

De-Regil LM, Peña-Rosas JP, Fernández-Gaxiola AC, Rayco-Solon P.

Cochrane Database Syst Rev. 2015 Dec 14;(12):CD007950. doi: 10.1002/14651858.CD007950.pub3. Review.

PMID:
26662928
17.

Neural tube defects among Mexican Americans living on the US-Mexico border: effects of folic acid and dietary folate.

Suarez L, Hendricks KA, Cooper SP, Sweeney AM, Hardy RJ, Larsen RD.

Am J Epidemiol. 2000 Dec 1;152(11):1017-23.

18.

Maternal occupational exposure to organic solvents during early pregnancy and risks of neural tube defects and orofacial clefts.

Desrosiers TA, Lawson CC, Meyer RE, Richardson DB, Daniels JL, Waters MA, van Wijngaarden E, Langlois PH, Romitti PA, Correa A, Olshan A; National Birth Defects Prevention Study..

Occup Environ Med. 2012 Jul;69(7):493-9. doi: 10.1136/oemed-2011-100245.

19.

Maternal body mass index and the association between folic acid supplements and neural tube defects.

Wang M, Wang ZP, Gao LJ, Gong R, Sun XH, Zhao ZT.

Acta Paediatr. 2013 Sep;102(9):908-13. doi: 10.1111/apa.12313.

PMID:
23750819
20.

Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis.

Goh YI, Bollano E, Einarson TR, Koren G.

J Obstet Gynaecol Can. 2006 Aug;28(8):680-9. Review.

PMID:
17022907
Items per page

Supplemental Content

Support Center